Evidence map›Paper›PMID 35044894›Full record

ArticleAnnals of the American Thoracic Society2022

Body Mass Index Recovery after Lung Transplant for Cystic Fibrosis.

Joseph B Pryor, Miranda C Bradford, Ann L Jennerich, Travis Y Hee Wai, Joseph M Pilewski, Siddhartha G Kapnadak, Moira L Aitken, Christopher H Goss, Kathleen J Ramos

Open access · greenAbstract read
In one paragraph

Article in Annals of the American Thoracic Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Observational
  2. Elexacaftor/tezacaftor/ivacaftor prescription in lung transplant recipients with cystic fibrosis in the US.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2025
    Article
  3. Elexacaftor-tezacaftor-ivacaftor pharmacokinetics with concurrent tacrolimus administration after lung transplant.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2025
    Observational
  4. Article
  5. Article
  6. Survival difference between high-risk and low-risk CFTR genotypes after lung transplant.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Joseph B PryorDepartment of General Internal Medicine.ORCID 0000-0002-1431-6589
Miranda C BradfordBiostatistics Epidemiology and Analytics in Research, Seattle Children's Research Institute, Seattle, Washington; and.
Ann L JennerichDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, and.ORCID 0000-0002-9194-8328
Travis Y Hee WaiDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, and.
Joseph M PilewskiDivision of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Siddhartha G KapnadakDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, and.
Moira L AitkenDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, and.
Christopher H GossDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, and.
Kathleen J RamosDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, and.
SleepMed · USUniversity of Pittsburgh · USUniversity of Washington · US

Funding

Transform Dissemination and Implementation Science in CTSA ProgramsUL1TR002319 · NCATS · UNIVERSITY OF WASHINGTON · PI John K. Amory · 2017 to 2026
$100.0M
Institute of Translational Health SciencesUL1TR000423 · NCATS · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2012 to 2016
$49.4M
Translational Research Center to Expedite Novel Therapies in Cystic FibrosisP30DK089507 · NIDDK · SEATTLE CHILDREN'S HOSPITAL · PI Christopher Hooper Goss · 2010 to 2026
$21.4M
Proof of Principle Evaluation of IV Gallium Nitrate in Patients with CFUM1HL119073 · NHLBI · UNIVERSITY OF WASHINGTON · PI GOSS, CHRISTOPHER HOOPER, SINGH, PRADEEP K · 2013 to 2017
$4.8M
OPTIMIZE - DCCU01HL114589 · NHLBI · SEATTLE CHILDREN'S HOSPITAL · PI HAMBLETT, NICOLE MAYER · 2013 to 2017
$3.3M
A Phase 1b, Multi-center Study of IV Gallium Nitrate in Patients with Cystic Fibrosis who are colonized with Nontuberculosis Mycobacterium (The ABATE Study).R01FD006848 · FDA · SEATTLE CHILDREN'S HOSPITAL · PI Christopher Hooper Goss, JERRY A NICK · 2020 to 2026
$3.1M
Phase 2 Study of Intravenous Gallium Nitrate in the Treatment of Cystic FibrosisR01FD003704 · FDA · UNIVERSITY OF WASHINGTON · PI GOSS, CHRISTOPHER HOOPER · 2009 to 2018
$2.0M
Predicting survival and planning for lung transplantation in severe cystic fibrosisK23HL138154 · NHLBI · UNIVERSITY OF WASHINGTON · PI RAMOS, KATHLEEN JESSICA · 2017 to 2021
$947k
Improving clinical outcomes after ICU transfer for acute respiratory failureK23HL128793 · NHLBI · UNIVERSITY OF WASHINGTON · PI JENNERICH, ANN LONG · 2017 to 2021
$941k
FDA HHS R01 FD003704FDA HHS R01 FD006848NCATS NIH HHS UL1 TR000423NCATS NIH HHS UL1 TR002319NHLBI NIH HHS K23 HL128793NHLBI NIH HHS K23 HL138154NHLBI NIH HHS U01 HL114589NHLBI NIH HHS UM1 HL119073NIDDK NIH HHS P30 DK089507NIH Clinical Center K23HL128793NIH Clinical Center K23HL138154
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cystic FibrosisLung TransplantationBody Mass IndexHumansProportional Hazards ModelsRetrospective StudiesBMIforced expiratory volume in 1 secondlung functionsurvivalunderweight

Identifiers

PMID35044894
PMCPMC9278631
OpenAlexW4205419992

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.